Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01012661 · ClinicalTrials.gov registry record · Phase 4

Evaluation of Pain With Lidocaine-Mixed Radiesse® Injectable Dermal Filler

A Phase 4 study of Nasolabial Folds, sponsored by Merz North America.

Completed
Registry status
Phase 4
Development phase
50
Enrollment target
2
Study locations

NCT01012661 is a Phase 4 study of Nasolabial Folds that has completed, run by Merz North America. The registered enrollment target is 50 participants, roughly in line with the 54-participant average among 4 other Nasolabial Folds trials with a reported enrollment target. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01012661, a Phase 4 study of Nasolabial Folds, has completed, sponsored by Merz North America.

COMPLETED
Registry status
Phase 4
Development phase
50 participants
Enrollment target
2
Study locations

Study Summary

To assess pain during nasolabial fold treatment using Radiesse® Injectable Dermal Filler mixed with lidocaine.

Conditions Studied

Nasolabial Folds

Interventions

  • DEVICE Radiesse® Injectable Dermal Filler Mixed with Lidocaine
  • DEVICE Radiesse® Injectable Dermal Filler without Lidocaine

Study Locations (2)

Maryland

  • - Rockville

New York

  • - New York

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2008-09
Est. Completion 2009-01
Phase Phase 4

Sponsor

Merz North America

35 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01012661

The ClinicalTrials.gov registry entry for NCT01012661 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 54-participant average among 4 other Nasolabial Folds trials with a reported enrollment target. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nasolabial Folds appearing as the primary indexed condition, and to 2 interventions - of which Radiesse® Injectable Dermal Filler Mixed with Lidocaine is the first listed.

NCT01012661 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, New York.

Frequently Asked Questions

What is clinical trial NCT01012661 about?

NCT01012661 is a clinical study titled "Evaluation of Pain With Lidocaine-Mixed Radiesse® Injectable Dermal Filler". To assess pain during nasolabial fold treatment using Radiesse® Injectable Dermal Filler mixed with lidocaine.

What is the current status of trial NCT01012661?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2008-09. Estimated completion is 2009-01.

What conditions does trial NCT01012661 study?

This clinical trial studies the following conditions: Nasolabial Folds.

What interventions are being tested in trial NCT01012661?

The interventions under investigation include: Radiesse® Injectable Dermal Filler Mixed with Lidocaine (DEVICE), Radiesse® Injectable Dermal Filler without Lidocaine (DEVICE).

Who is sponsoring clinical trial NCT01012661?

This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01012661 being conducted?

This trial has 2 study locations across Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Nasolabial Folds

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Nasolabial Folds

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.